Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology|December 1, 1994
Primary central nervous system recurrence after paclitaxel therapy for epithelial ovarian malignancyV L Seewaldt, D C Figge, B E Greer, et al.
American Journal of Obstetrics and Gynecology|June 1, 1996
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancerJ M Cain, C Collins, S Petersdorf, et al.
Obstetrics and Gynecology|September 1, 1981
Estrogen replacement therapyH L Judd, R E Cleary, W T Creasman, et al.
American Journal of Obstetrics and Gynecology|June 1, 1994
Paclitaxel (Taxol) treatment for refractory ovarian cancer: phase II clinical trialV L Seewaldt, B E Greer, J M Cain, et al.
Gynecologic Oncology|June 1, 1987
Radical reirradiation for recurrent or second primary carcinoma of the female reproductive tractA H Russell, W J Koh, K Markette, et al.
Gynecologic Oncology|September 1, 1990
Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessmentJ M Cain, G K Ellis, C Collins, et al.
Gynecologic Oncology|October 1, 1987
Adjunctive hysterectomy following radiation therapy for bulky carcinoma of the uterine cervix: prognostic implications of tumor persistenceA H Russell, A R Burt, M Ek, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1987
High dose para-aortic lymph node irradiation for gynecologic cancer: technique, toxicity, and resultsA H Russell, D C Jones, K J Russell, et al.
American Journal of Obstetrics and Gynecology|June 1, 1995
The use of intraoperative radiation therapy in radical salvage for recurrent cervical cancer: outcome and toxicityK J Stelzer, W J Koh, B E Greer, et al.
Gynecologic Oncology|July 1, 1989
Fetal and maternal considerations in the management of stage I-B cervical cancer during pregnancyB E Greer, T R Easterling, D A McLennan, et al.
Pageof 4